share_log

Scotiabank Initiates Coverage On INmune Bio With Sector Outperform Rating, Announces Price Target of $22

Scotiabank Initiates Coverage On INmune Bio With Sector Outperform Rating, Announces Price Target of $22

Scotiabank發起對inmune bio的板塊表現評級,宣佈目標股價爲22美元
Benzinga ·  08/22 20:32  · 評級/大行評級

Scotiabank analyst George Farmer initiates coverage on INmune Bio (NASDAQ:INMB) with a Sector Outperform rating and announces Price Target of $22.

Scotiabank分析師George Farmer開始對inmune bio(納斯達克:INMB)進行覆蓋,並給予板塊超越評級,並公佈22美元的目標價。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論